28 June 2001 PRISTINA, 27 June (KosovaLive)–Officials at the Department of Health and Social Welfare (DHSW) are struggling to strike a delicate balance involving medicine, politics, and international law. They are trying to decide whether to allow the use of a potentially life-saving drug known as ribavirin to combat the outbreak of Crimean-Congo hemorrhagic fever, even though it would require […]
You have reached a premium content area of Transitions. To read this entire article please login if you are already a Transitions subscriber.
Not a subscriber?
Subscribe today for access to:
Full access to the website and archive of over 26,000 articles
Exclusive monthly, members-only newsletter offering behind-the-scenes views from our contributing writers
A guest, two-month subscription to share with a friend
